Skip to main content
. 2020 Mar 26;2:15. doi: 10.1186/s42238-020-00022-4

Table 2.

THC pharmacokinetic parameters after inhalation

Group I
10 ± 0.1 mg
Group II
15 ± 0.1 mg
Group III
20 ± 0.1 mg
Group IV
25 ± 0.1 mg
Δ9-THC Cmax (ng/mL) 35.43 ± 5.97 51.47 ± 13.79 72.37 ± 15.93 88.63 ± 14.75
AUC0-∞ (ng min/mL) 441.59 ± 88.49 624 ± 123.56 698.35 ± 174.98 971.36 ± 310.4
Tmax (min) 3.666 ± 0.471 3.333 ± 0.471 2.666 ± 0.942 3 ± 0.816

Each THC dosage group concise of four healthy volunteers. Both Δ9-THC Cmax and AUC0-∞ measured in plasma of the volunteers and calculated from the same data, are showing a linear increase in mean maximum plasma concentration of THC (Cmax) and area under the curve (AUC) both with no change in the time needed to reach such concentration

THC Cmax Tetrahydrocannabinol maximum concentration, AUC Area under the curve, Tmax time to reach maximum concentration